Keywords: 5-CSRTT, 5-choice serial reaction time task; 5-HT, 5-hydroxytryptamine; ADHD, attention-deficit/hyperactivity disorder; ASR, acoustic startle response; BL, baseline; DOI, 2,5-dimethoxy-4-iodoamphetamine; HI, high impulsive; HR, high reward; ISI, interstim
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Effects of LSD on grooming behavior in serotonin transporter heterozygous (Sert+/−) mice
Keywords: DOI, 2,5-dimethoxy-4-iodoamphetamine; MDMA, 3,4-methylenedioxymethamphetamine; ASD, autism spectrum disorders; LSD, lysergic acid diethylamide; MAOI, monoamine oxidase inhibitor; OCD, obsessive compulsive disorder; 5-HT, serotonin; SS, serotonin syndrome;
The effect of the sigma-1 receptor selective compound LS-1-137 on the DOI-induced head twitch response in mice
Keywords: DOI, 2,5-dimethoxy-4-iodoamphetamine; HTR, Head twitch response; TS, Tourette Syndrome; 5-hydroxytryptamine, 5-HT2; Dimethyl sulfoxide, DMSOHead twitch response; Sigma-1 receptors; 2,5-dimethoxy-4-iodoamphetamine (DOI); Neuropsychiatric disorders; Antipsy
Heterocomplex formation of 5-HT2A-mGlu2 and its relevance for cellular signaling cascades
Keywords: mGlu2; 5-HT2A; Heterocomplex; GPCR crosstalk5-HT, 5-hydroxytryptamine; 5-HT2A, serotonin receptor 2A; DOI, 2,5-dimethoxy-4-iodoamphetamine; FRET, fluorescence resonance energy transfer; GPCR, G protein-coupled receptor; HTRF, homogenous time-resolved FRET
Possible involvement of serotonin 5-HT2 receptor in the regulation of feeding behavior through the histaminergic system
Keywords: Histamine; H1 receptor; 5-HT receptor; Anorexia; Schizophrenia; Antischizophrenic drugs5-HT, serotonin; DOI, 2,5-dimethoxy-4-iodoamphetamine; H1R-KO, H1 receptor-knock out mice; HPLC, high-performance liquid chromatography; WT, wild type; ANOVA, analysis
Current approaches and issues in non-clinical evaluation of abuse and dependence
Keywords: CB, cannabinoid; CNS, Central Nervous System; CPP, conditioned place preference; DOI, 2,5-dimethoxy-4-iodoamphetamine; EMA, European Medicines Agency; FI, Fixed Interval; FR, Fixed Ratio; FDA, Food and Drug Administration; GABA, gamma-aminobutyric acid; G
Physiological and pharmacological implications of beta-arrestin regulation
Keywords: G protein coupled receptors; Seven transmembrane spanning receptors; GRK; Beta-arrestin; Functional selectivity; Knockout mouse models; Drug discovery; Receptor regulation; PhysiologyΔ9-THC, Δ9-tetrahydrocannabinol; DOI, 2,5-dimethoxy-4-iodoamphetamine; C
Repeated administration of Yokukansan inhibits DOI-induced head-twitch response and decreases expression of 5-hydroxytryptamine (5-HT)2A receptors in the prefrontal cortex
Keywords: AD, Alzheimer's disease; ANOVA, analysis of variance; BPSD, behavioral and psychological symptoms of dementia; DOI, 2,5-dimethoxy-4-iodoamphetamine; EPS, extrapyramidal symptoms; LSD, lysergic acid diethylamide; 5-HT, serotonin; YKS, Yokukansan.5-HT2A rec